Tech Company Financing Transactions
EnBiotix Funding Round
EnBiotix, based in Cambridge, raised $3.1 million from private investors.
Transaction Overview
Company Name
Announced On
10/2/2019
Transaction Type
Venture Equity
Amount
$3,148,176
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Massachusetts Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
EnBiotix is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Wager
Vice President
Diane Joseph-McCarthy
VP - Bus. Development
Michael Garrett
VP - Bus. Development
Benjamin Perrone
Browse more venture capital transactions:
Prev: 10/2/2019: Chronometriq venture capital transaction
Next: 10/2/2019: BurstIQ venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs